The Toronto Stock Exchange approved CRH Medical's intention to renew its normal course issuer bid.
Here's what you should know:
1. CRH may purchase up to 7 million of its common shares, representing 9.74 percent of its outstanding common shares.
2. CRH currently has 72.3 million in common shares and a public float of 70.44 million.
3. CRH will fund the bid with generated cash flow.